Remove tag united-nations
article thumbnail

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Rethinking Clinical Trials

Fleurence, PhD, MSc Senior Advisor National Institutes of Health Joshua M. To address this crisis, the NIH is embarking on a National Initiative on Hepatitis C. The hope is that we can have coherent and national organization to roll out this program and get the point of care tests in places where it really matters to have these tests.

article thumbnail

Cannabinoids receptors: popular preclinical target but banned in 137 countries

Pharmaceutical Technology

Despite this, the medical use of cannabinoid drugs is heavily restricted, including being banned in 137 countries, according to the United Nations. Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds January 20, 2023: Collaborative Pragmatic Trials in Action: EVOLVE-MI (Mikhail Kosiborod, MD)

Rethinking Clinical Trials

– The randomization unit is at the patient level, and they do sign an informed consent. Tags #pctGR, @Collaboratory1 The post Grand Rounds January 20, 2023: Collaborative Pragmatic Trials in Action: EVOLVE-MI (Mikhail Kosiborod, MD) appeared first on Rethinking Clinical Trials. Can it be done under an IND.

Trials 130
article thumbnail

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

They are estimated at $937 per capita, compared with $284 in Switzerland, $80 in the United Kingdom, and an OECD average of $173. Hospitals receive $1 out of every $3 spent on health care, and the United States is projected to spend about $1.3 An analysis found that only 5.6% trillion for hospital care alone in 2019.

Drugs 222
article thumbnail

American health is in for a “world of hurt”

World of DTC Marketing

The estimates are thought to be particularly reliable, as the team corrected for current underestimates of weight given by individuals in national surveys. Healthier eating could save the United States more than $50 billion a year in health care costs associated with heart disease, stroke, type 2 diabetes and related illnesses.

article thumbnail

Gene Silencing Porphyria Treatment, Givlaari, Finally Wins Over England’s NICE Amid Stellar Long-Term Data

XTalks

After initial rejection from the National Institute for Health and Care Excellence (NICE) last year, the non-departmental public body of the Department of Health in England has now given the green light to the gene silencing treatment Givlaari (givosiran) for the treatment of the rare metabolic disorder, acute intermittent porphyria (AIP).

article thumbnail

FTC codifies its Enforcement policy for “Made in the USA” Claims; False “Made in the USA” Claims May Now Result in a Monetary Penalty

FDA Law Blog

The new rule applies not only to product labeling, but to any “mail order catalog” or “mail order promotional material” that includes a seal, mark, tag, or stamp that labels a product as having been made in the United States. For false or misleading qualified MUSA claims, FTC authority remains limited to injunctive relief.